Effects of Resistance Exercise on Blood Glucose in Post-menopausal Women With Type 1 Diabetes
Launched by UNIVERSITY OF ALBERTA · Jan 10, 2022
Trial Information
Current as of July 23, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different types of resistance exercise affect blood sugar levels in post-menopausal women with type 1 diabetes. The researchers want to understand whether a lighter weight, high repetition workout leads to more significant drops in blood sugar during exercise compared to a moderate weight, lower repetition workout, which might carry a higher risk of low blood sugar after exercising. The goal is to help women with type 1 diabetes safely incorporate exercise into their lives, especially since physical activity can offer many health benefits.
To be eligible for the study, participants must be women who have had type 1 diabetes for at least a year and are at least one year past menopause. They should be physically able to perform the exercises and have a specific level of blood sugar control (an HbA1c level of less than 10%). Participants will attend sessions at the University of Alberta, where they will engage in the exercise programs and have their blood sugar levels monitored. This trial is an important step in understanding how to safely encourage more physical activity among women with type 1 diabetes, especially as they age.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • female
- • type 1 diabetes diagnosed for at least 1 year
- • at least 12 months since last menstrual period
- • physically able and willing to perform resistance exercise
- • HbA1c \< 10%
- • residing near Edmonton, Alberta / able to attend laboratory based sessions at the University of Alberta
- Exclusion Criteria:
- • Individuals with HbA1c \>9.9%
- • Frequent and unpredictable hypoglycaemia
- • A change in insulin management strategy within two months of the study
- • Blood pressure \> 144/95,
- • Severe peripheral neuropathy,
- • A history of cardiovascular disease
- • Musculoskeletal injuries affecting the ability to perform resistance exercise.
- • Individuals who are treated with medications (other than insulin) that affect glucose metabolism (e.g. atypical antipsychotics, corticosteroids)
- • A body mass index \>30kg/m2,
- • Smoking
- • Moderate to high alcohol intake (\>2 drinks per day)
About University Of Alberta
The University of Alberta, a leading research institution in Canada, is dedicated to advancing healthcare through innovative clinical trials. With a strong commitment to scientific excellence and community health, the university facilitates cutting-edge research across various medical disciplines. Its interdisciplinary approach fosters collaboration among researchers, clinicians, and students, ensuring that clinical trials are designed and conducted with the utmost rigor and ethical standards. By leveraging its extensive resources and expertise, the University of Alberta aims to translate research findings into meaningful advancements in patient care and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Edmonton, Alberta, Canada
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials